Articles in Scholarly Journals [Incomplete List]

1. A subset of functional effector-memory CD8+ T lymphocytes in human immunodeficiency virus-infected patients
   Immunology, vol. 121, no. 3, pp. 405–415, 2007
2. Macrophage reservoirs or how HIV fuels the disease
   Future Microbiology, vol. 2, no. 1, pp. 13–16, 2007
3. Development and Characterization of Ten Monoclonal Anti-Vpr Antibodies
   AIDS Research and Human Retroviruses, vol. 22, no. 7, pp. 630–639, 2006
4. HIV and Inflammation
   Current HIV Research, vol. 3, no. 3, pp. 243–259, 2005
5. Synthetic Vpr Protein Activates Activator Protein-1, c-Jun N-terminal Kinase, and NF- B and Stimulates HIV-1 Transcription in Promonocytic Cells and Primary Macrophages
   Journal of Biological Chemistry, vol. 280, no. 52, pp. 42557–42567, 2005
6. Mixed Cytomegalovirus Glycoprotein B Genotypes in Immunocompromised Patients
   Clinical Infectious Diseases, vol. 39, no. 2, pp. 155–161, 2004
7. CXCR4-mediated T cell apoptosis in human immunodeficiency virus infection
   Journal of General Virology, vol. 85, no. 6, pp. 1471–1478, 2004
8. Exogenous Nef Protein Activates NF-kappa B, AP-1, and c-Jun N-Terminal Kinase and Stimulates HIV Transcription in Promonocytic Cells. ROLE IN AIDS PATHOGENESIS
   Journal of Biological Chemistry, vol. 278, no. 4, pp. 2219–2227, 2003
9. Macrophage Activation and HIV Infection: Can the Trojan Horse Turn into a Fortress?
   Current Molecular Medicine, vol. 2, no. 8, pp. 723–738, 2002
10. Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells?
    Trends in Immunology, vol. 22, no. 5, pp. 256–260, 2001
11. Tumor Necrosis Factor (TNF)-alpha and TNF Receptors in Viral Pathogenesis
    Proceedings of the Society for Experimental Biology and Medicine, vol. 223, no. 3, pp. 241–257, 2000
12. Nature, vol. 395, no. 6698, pp. 189–194, 1998
13. Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway
    Science, vol. 275, no. 5305, pp. 1481–1485, 1997
14. Comparison of p24 measurement by ELISA versus indicator cells for detecting residual HIV infectivity in vitro
    Journal of Virological Methods, vol. 58, no. 1-2, pp. 167–173, 1996
15. Interleukin-13 alters the activation state of murine macrophagesin vitro: Comparison with interleukin-4 and interferon-?
    European Journal of Immunology, vol. 24, no. 6, pp. 1441–1445, 1994
16. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro
    Journal of Experimental Medicine, vol. 178, no. 2, pp. 743–747, 1993